目前对新型冠状病毒的认识:分子发病机制、诊断和治疗方法

N. Jha, Madhan Jeyaraman, gupta, S. Ojha, K. Dua, D. Chellappan, S. Muthu, Ankur Sharma, S. Jha, R. Jain, Naveen Jeyaraman, Prajwal Gs, Rohit Satyam, Fahad Khan, P. Pandey, Nandini Verma, S. Singh, S. Roychoudhury, S. Dholpuria, J. Ruokolainen, K. Kesari
{"title":"目前对新型冠状病毒的认识:分子发病机制、诊断和治疗方法","authors":"N. Jha, Madhan Jeyaraman, gupta, S. Ojha, K. Dua, D. Chellappan, S. Muthu, Ankur Sharma, S. Jha, R. Jain, Naveen Jeyaraman, Prajwal Gs, Rohit Satyam, Fahad Khan, P. Pandey, Nandini Verma, S. Singh, S. Roychoudhury, S. Dholpuria, J. Ruokolainen, K. Kesari","doi":"10.3390/IMMUNO1010004","DOIUrl":null,"url":null,"abstract":"An outbreak of “Pneumonia of Unknown Etiology” occurred in Wuhan, China, in late December 2019. Later, the agent factor was identified and coined as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the disease was named coronavirus disease 2019 (COVID-19). In a shorter period, this newly emergent infection brought the world to a standstill. On 11 March 2020, the WHO declared COVID-19 as a pandemic. Researchers across the globe have joined their hands to investigate SARS-CoV-2 in terms of pathogenicity, transmissibility, and deduce therapeutics to subjugate this infection. The researchers and scholars practicing different arts of medicine are on an extensive quest to come up with safer ways to curb the pathological implications of this viral infection. A huge number of clinical trials are underway from the branch of allopathy and naturopathy. Besides, a paradigm shift on cellular therapy and nano-medicine protocols has to be optimized for better clinical and functional outcomes of COVID-19-affected individuals. This article unveils a comprehensive review of the pathogenesis mode of spread, and various treatment modalities to combat COVID-19 disease.","PeriodicalId":55599,"journal":{"name":"Immuno-Analyse & Biologie Specialisee","volume":"14 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"18","resultStr":"{\"title\":\"Current Understanding of Novel Coronavirus: Molecular Pathogenesis, Diagnosis, and Treatment Approaches\",\"authors\":\"N. Jha, Madhan Jeyaraman, gupta, S. Ojha, K. Dua, D. Chellappan, S. Muthu, Ankur Sharma, S. Jha, R. Jain, Naveen Jeyaraman, Prajwal Gs, Rohit Satyam, Fahad Khan, P. Pandey, Nandini Verma, S. Singh, S. Roychoudhury, S. Dholpuria, J. Ruokolainen, K. Kesari\",\"doi\":\"10.3390/IMMUNO1010004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"An outbreak of “Pneumonia of Unknown Etiology” occurred in Wuhan, China, in late December 2019. Later, the agent factor was identified and coined as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the disease was named coronavirus disease 2019 (COVID-19). In a shorter period, this newly emergent infection brought the world to a standstill. On 11 March 2020, the WHO declared COVID-19 as a pandemic. Researchers across the globe have joined their hands to investigate SARS-CoV-2 in terms of pathogenicity, transmissibility, and deduce therapeutics to subjugate this infection. The researchers and scholars practicing different arts of medicine are on an extensive quest to come up with safer ways to curb the pathological implications of this viral infection. A huge number of clinical trials are underway from the branch of allopathy and naturopathy. Besides, a paradigm shift on cellular therapy and nano-medicine protocols has to be optimized for better clinical and functional outcomes of COVID-19-affected individuals. This article unveils a comprehensive review of the pathogenesis mode of spread, and various treatment modalities to combat COVID-19 disease.\",\"PeriodicalId\":55599,\"journal\":{\"name\":\"Immuno-Analyse & Biologie Specialisee\",\"volume\":\"14 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-03-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"18\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immuno-Analyse & Biologie Specialisee\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/IMMUNO1010004\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-Analyse & Biologie Specialisee","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/IMMUNO1010004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 18

摘要

2019年12月下旬,中国武汉爆发了“不明原因肺炎”疫情。随后,该因子被确定并命名为“严重急性呼吸综合征冠状病毒2”(SARS-CoV-2),并被命名为“冠状病毒病2019”(COVID-19)。在较短的时间内,这种新出现的感染使世界陷入停滞。2020年3月11日,世卫组织宣布COVID-19为大流行。世界各地的研究人员已经联手调查SARS-CoV-2的致病性、传播性,并推断出治疗方法来征服这种感染。从事不同医学艺术的研究人员和学者正在广泛寻求更安全的方法来遏制这种病毒感染的病理影响。对抗疗法和自然疗法的分支正在进行大量的临床试验。此外,必须优化细胞治疗和纳米医学方案的范式转变,以使受covid -19影响的个体获得更好的临床和功能结果。本文综述了新型冠状病毒病的发病机制、传播方式和各种治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Current Understanding of Novel Coronavirus: Molecular Pathogenesis, Diagnosis, and Treatment Approaches
An outbreak of “Pneumonia of Unknown Etiology” occurred in Wuhan, China, in late December 2019. Later, the agent factor was identified and coined as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the disease was named coronavirus disease 2019 (COVID-19). In a shorter period, this newly emergent infection brought the world to a standstill. On 11 March 2020, the WHO declared COVID-19 as a pandemic. Researchers across the globe have joined their hands to investigate SARS-CoV-2 in terms of pathogenicity, transmissibility, and deduce therapeutics to subjugate this infection. The researchers and scholars practicing different arts of medicine are on an extensive quest to come up with safer ways to curb the pathological implications of this viral infection. A huge number of clinical trials are underway from the branch of allopathy and naturopathy. Besides, a paradigm shift on cellular therapy and nano-medicine protocols has to be optimized for better clinical and functional outcomes of COVID-19-affected individuals. This article unveils a comprehensive review of the pathogenesis mode of spread, and various treatment modalities to combat COVID-19 disease.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Immuno-Analyse & Biologie Specialisee
Immuno-Analyse & Biologie Specialisee 医学-医学实验技术
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
期刊最新文献
Increased COVID-19 Mortality and Deficient SARS-CoV-2 Immune Response Are Not Associated with Higher Levels of Endemic Coronavirus Antibodies Bone Marrow: The Central Immune System The Importance of Neutrophils in Osteoarthritis: Current Concepts and Therapeutic Perspectives Immunotherapeutic Development of a Tri-Specific NK Cell Engager Recognizing BCMA Inflammatory Profile of Th9 Cells and Their Protective Potential in Helminth Infections
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1